The Treg/Th17 cell ratio is reduced in the skin lesions of patients with pyoderma gangrenosum-Reference-Cited by-同舟云学术

The Treg/Th17 cell ratio is reduced in the skin lesions of patients with pyoderma gangrenosum

Published:2015-05-16 Issue:1 Volume:173 Page:275-278
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Caproni M.¹,Antiga E.¹,Volpi W.¹,Verdelli A.¹,Venegoni L.²,Quaglino P.³,Fabbri P.¹,Marzano A.V.²

Affiliation:

1. Department of Surgery and Translational Medicine; Section of Dermatology; University of Florence; Viale Michelangelo 41 50125 Florence Italy

2. Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti; Unità Operativa di Dermatologia; IRCCS Fondazione Ca’ Granda; Ospedale Maggiore Policlinico; Università degli Studi di Milano; Milan Italy

3. Department of Biomedical Sciences and Human Oncology; 1st Dermatologic Clinic; University of Turin; Turin Italy

Funder

Ministry of Instruction

University and Research of the Italian Government

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.13670/fullpdf

Reference15 articles.

1. Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet's syndrome: a comprehensive review and disease classification criteria;Marzano;Clin Rev Allergy Immunol,2013

2. What do autoinflammatory syndromes teach about common cutaneous diseases such as pyoderma gangrenosum? A commentary;Butler;Dermatol Clin,2013

3. Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases;Marzano;Clin Exp Immunol,2010

4. Interleukin 23 expression in pyoderma gangrenosum and targeted therapy with ustekinumab;Guenova;Arch Dermatol,2011

5. Mechanisms of impaired regulation by CD4+ CD25+ FOXP3+ regulatory T cells in human autoimmune diseases;Buckner;Nat Rev Immunol,2010

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Postoperative and Peristomal Pyoderma Gangrenosum;Dermatologic Clinics;2023-12

2. Genetic mutations in pyoderma gangrenosum, hidradenitis suppurativa, and associated autoinflammatory syndromes: Insights into pathogenic mechanisms and shared pathways;The Journal of Dermatology;2023-11-30

3. New treatment of pyoderma gangrenosum and hidradenitis suppurativa: A review;The Journal of Dermatology;2023-11-27

4. Cutaneous manifestations of inflammatory bowel disease: basic characteristics, therapy, and potential pathophysiological associations;Frontiers in Immunology;2023-10-26

5. Targeted therapy with ixekizumab in pyoderma gangrenosum: A case series and a literature overview;JAAD Case Reports;2023-07